The FDA has lost no time in approving the first drug under its recently launched Commissioner's National Priority Voucher (CNPV) programme, clearing an antibiotic manufactured in the US. The fast ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. As a way of dealing with high demand, the age-old practice of forming a long, orderly queue has something to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results